Epigenetics: Immunization is passed on to offspring

Adaptations to infection shown to be passed on over several generations in mice

Does an infection affect the immunity of subsequent generations? Prof. Andeas Schlitzer, member of ImmunoSensation² and the Life & Medical Sciences Institute (LIMES) at the University of Bonn, Prof. Dr. Mihai G. Netea from Radboud University (Netherlands), together with researchers from Saarland University, Lausanne (Switzerland) and Athens (Greece), have investigated this. Mouse sires that either had previously overcome infection with fungi or were stimulated with fungal substances, passed on their improved protection over several generations. The team simultaneously demonstrated an improved immune response that was passed on to the offspring. The study has now been published in Nature Immunology.

The scientists infected male mice with thrush fungi (Candida albicans). After surviving the infection, the animals were mated with completely healthy females. The researchers compared the resulting children with offspring from pairs of mice that had not previously been infected with Candida. To experimentally examine the status of the immune system, the team infected the males of the subsequent generation of mice with coliform bacteria. The offspring of the male mice previously exposed to Candida were found to be significantly better protected from subsequent E. coli infection than the offspring of the uninfected male mice. This effect was still evident in the next generation.

Publication

Natalie Katzmarski, Jorge Domínguez-Andrés, Branko Cirovic, Georgios Renieris, Eleonora Ciarlo, Didier Le Roy, Konstantin Lepikhov, Kathrin Kattler, Gilles Gasparoni, Kristian Händler, Heidi Theis, Marc Beyer, Jos W. M. van der Meer, Leo A. B. Joosten, Jörn Walter, Joachim L. Schultze, Thierry Roger, Evangelos J. Giamarellos-Bourboulis, Andreas Schlitzer, Mihai G. Netea: Transmission of trained immunity and heterologous resistance to infections across generations, Nature Immunology, DOI: 10.1038/s41590-021-01052-7.

Contact

Prof. Dr. Andreas Schlitzer

Quantitative Systembiologie

LIMES-Institut (Life and Medical Sciences Bonn)

Universität Bonn

Tel. +49 2287362847

E-Mail: andreas.schlitzer(at)uni-bonn.de

Prof. Dr. Mihai G. Netea

Radboud university medical center und
LIMES-Institut der Universität Bonn

Tel. +31 243618819

E-Mail: Mihai.Netea(at)radboudumc.nl

Related news

News categories: Publication

B cells maintain antigen presentation in the splenic marginal zone

25 Feb 2026 —A team of international researchers, including ImmunoSensation³ members Prof. Niels Lemmermann and Prof. Andreas Schlitzer, shows that B cells support antiviral CD8⁺ T-cell responses beyond antibody production. In a murine CMV model, B-cell deficiency weakened virus-specific CD8⁺ T-cell responses. Mechanistically, B-cell-derived lymphotoxin β maintained CD169⁺ macrophages and Langerin⁺ cDC1 cells in the splenic marginal zone, enabling efficient T-cell priming. The study was published in Cellular & Molecular Immunology.

Full publication

News categories: Publication

New findings on infection with the Epstein-Barr virus

20 Feb 2026 —The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown. Bonn researchers have now identified genetic and non-genetic factors that help the body fight EBV. To do this, they evaluated genome sequencing data, which is actually intended for characterizing the human genome, in a new way. Using the new technique, they were able to estimate the amount of EBV in the blood and find correlations in large health data sets. Their findings have now been published in the renowned journal Nature.

View entry

News categories: Publication

New insights into the human immune defense against poxviruses

22 Jan 2026 —An international research team involving Bonn scientist has made an important contribution to understanding the human immune response to poxviruses: The scientists were able to show for the first time that different human cell types recognize poxviruses via different sensors in order to trigger inflammatory responses. At the same time, the team developed the world's first nanobodies that can specifically block the DNA sensor AIM2 – a tool that opens up new possibilities for inflammation and infection research. The paper has now been published in The EMBO Journal.

View entry

Back to the news overview